Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
|
US |
|
B
|
BK Technologies Corp
AMEX:BKTI
|
US |
|
10X Genomics Inc
NASDAQ:TXG
|
US |
Multiples-Based Value
The Multiples-Based Value for
Supernus Pharmaceuticals Inc (SUPN) under the Base Case is 34.32 USD.
Compared with the current market price of 43.86 USD, the stock appears
Overvalued by 22% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.